structure of 4-[(2-Chloro-1,3-thiazol-5-yl)sulfonyl]morpholine

4-[(2-Chloro-1,3-thiazol-5-yl)sulfonyl]morpholine

CAS No.: 1000925-29-0
M. Wt: 268.741
M. Fa: C7H9ClN2O3S2
InChI Key: OIQRCTCSXGNYAO-UHFFFAOYSA-N

Names and Identifiers of 1000925-29-0

CAS Number

1000925-29-0

EC Number

851-563-1

MDL Number

MFCD09863302

IUPAC Name

4-[(2-chloro-1,3-thiazol-5-yl)sulfonyl]morpholine

InChI

InChI=1S/C7H9ClN2O3S2/c8-7-9-5-6(14-7)15(11,12)10-1-3-13-4-2-10/h5H,1-4H2

InChIKey

OIQRCTCSXGNYAO-UHFFFAOYSA-N

Canonical SMILES

C1COCCN1S(=O)(=O)C2=CN=C(S2)Cl

UNSPSC Code

12352100

Physical and chemical properties of 1000925-29-0

Boiling Point

457.1±55.0 °C at 760 mmHg

Density

1.6±0.1 g/cm3

Exact Mass

267.974304

Flash Point

230.3±31.5 °C

H Bond Acceptors

4

H Bond Donors

0

Index of Refraction

1.602

LogP

-0.16

Molecular Formula

C7H9ClN2O3S2

Molecular Weight

268.741

Vapour Pressure

0.0±1.1 mmHg at 25°C

Safety Information of 1000925-29-0

Pictograms

Signal Word

 Warning

Safety Data Sheet
Supports customized editing of SDS information and downloading in PDF documents.

Interaction Studies of 1000925-29-0

Interaction studies involving 4-[(2-Chloro-1,3-thiazol-5-yl)sulfonyl]morpholine focus on its binding affinity to various biological targets. Preliminary studies suggest that this compound may inhibit specific enzymes or receptors implicated in disease processes. Further research is needed to elucidate these interactions fully and determine their therapeutic implications.

Biological Activity of 1000925-29-0

Research indicates that 4-[(2-Chloro-1,3-thiazol-5-yl)sulfonyl]morpholine exhibits significant biological activity, particularly in antimicrobial and antitumor domains. Its structure allows it to interact with biological targets effectively, making it a candidate for further pharmacological studies.

Antimicrobial Activity

Studies have shown that similar thiazole-based compounds possess antimicrobial properties against various bacterial strains.

Antitumor Activity

Compounds with similar structures have been evaluated for their antitumor efficacy, suggesting that 4-[(2-Chloro-1,3-thiazol-5-yl)sulfonyl]morpholine may also exhibit such properties.